Platelet activation in the hypertensive disorders of pregnancy

Bibliography

• WITTMANN BK, MURPHY KJ, KING JF, YUEN BH, SHAW D, WITTMAN AG: Maternal mortality in British Columbia in 1971-1986. Can. Med. Assoc. (1988) 139:37–40.
   PubMed Web of Science ®Google Scholar
• HENRIKSEN T: Hypertension in pregnancy and preeclampsia-diagnosis and treatment. Scand. j Rheurnatol Sapp]. (1998) 107:86–91.
   PubMed Web of Science ®Google Scholar
• MAHLER H: The safe motherhood initiative: a call to action: Lancet (1987) i:668–670.
   Google Scholar
• DUDLEY L: Maternal mortality associatedwith hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. &I. Obstet. Cynaecol (1992) 99:547–553.
   PubMed Web of Science ®Google Scholar
• REDMAN CW: Current topic: pre-eclampsia and the placenta. Placenta (1991) 12:301–308.
   PubMed Web of Science ®Google Scholar
• ••Very good overview of the pathophysiologyof pre-eclampsia and hypertensive disorders of pregnancy.
   Google Scholar
• WHIGHAM KA, HOWIE PW, DRUMMOND AH, PRENTICE CR: Abnormal platelet function in pre-eclampsia. Br. .1 Obstet. Cynaecol (1978) 85(1):28–32.
   Google Scholar
• BISWAS A, ARULKUMARAN S, RATNAM SS: Disorders of platelets in pregnancy. Obstet. Cynecol Surv. (1994) 49(8):585–594.
   PubMedGoogle Scholar
• PILLAI M: Platelets and pregnancy. Br. .1 Obstet. Cynaecol (1993) 100(3):201–204.
   Google Scholar
• JAREMO P, LINDAHL TL, LENNMARKEN C, FORSGREN H: The use of platelet density and volume measurements to estimate the severity of preeclampsia. Eur.j Clin. Investig. (2000) 30(12):1113–1118.
   PubMed Web of Science ®Google Scholar
• WALKER JJ, CAMERON AD, BJORNSSON S, SINGER CR, FRASER C: Can platelet volume predict progressive hypertensive disease in pregnancy? Am. Obstet. Cynecol (1989) 161 (3):676–679.
   Web of Science ®Google Scholar
• REDMAN CW, BONNAR J, BEILIN L: Early platelet consumption in pre-eclampsia. Br. Med. (1978) 1(6111):467–469.
   PubMed Web of Science ®Google Scholar
• HOWARTH S, MARSHALL LR, BARR AL, EVANS S, PONTRE M, RYAN N: Platelet indices during normal pregnancy and pre-eclampsia. Br. Blamed. Sci. (1999) 56(1):20–22.
   PubMed Web of Science ®Google Scholar
• RABINI RA, SALVOLINI E, STAFFOLANI R et al.: Biochemical-morphological modifications of platelet membranes during pregnancy-induced hypertension. Exp. Ma Pathol (1995) 63(3):175–185.
   PubMed Web of Science ®Google Scholar
• ARUMANAYAGAM M, ROGERS M: Platelet sodium pump and sodium potassium cotransport activity in nonpregnant, normotensive, and hypertensive pregnant women. Hypertens. Pregnancy (1999) 18(1):35–44.
   PubMed Web of Science ®Google Scholar
• SHANG T, QIAO C: [Study on the activity of platelets protein kinase C in patients with pregnancy induced hypertension]. Chung Hua Fu Chan Ko Tsa Chih (1998) 33 (4):201–203.
   Google Scholar
• COATA G, FRUSCA T, BARANZELLI D, COSMI EV, DI RENZO GC, ANCESCHI MM: Abnormal platelet lipid membrane composition in pregnancy induced hypertension. I. Perinatal Med. (1992) 20(2):123–127.
   PubMed Web of Science ®Google Scholar
• KLOCKENBUSCH W, HOHLFELD T, WILHELM M, SOMVILLE T, SCHROR K: Platelet PGI2 receptor affinity is reduced in pre-eclampsia. Br. Clin. Pharmacol (1996) 41(6):616–618.
   PubMed Web of Science ®Google Scholar
• MASSE J, FOREST IC, MOUTQUIN JM, DEGRANDPRE P, FOREST VI: A prospective longitudinal study of platelet angiotensin II receptors for the prediction of preeclampsia. Clin. Biochern. (1998) 31(4):251–255.
   PubMed Web of Science ®Google Scholar
• SANCHEZ A, SAIZ J, SAEZ B, CARRASCO S, DIAZ R: Platelet alpha 2-adrenoceptor density in pregnancy-induced hypertensive patients: effect of epidural analgesia. Hypertens. (1992) 10(8):831–837.
   Web of Science ®Google Scholar
• GRAVES SW, MOORE TJ, SEELY EW: Increased platelet angiotensin II receptor number in pregnancy-induced hypertension. Hypertension (1992) 20(5):627–632.
   PubMed Web of Science ®Google Scholar
• YANG Y, JONES DM, PAWLAK MA, MACDONALD GJ, DUGGAN KA: Accuracy of single concentration estimations of platelet angiotensin II receptor number. Its usefulness in screening for pregnancy-induced hypertension. Am. .1. Hypertens. (1994) 7(11):989–995.
   Google Scholar
• SOCOL ML, WEINER CP, LOUIS G, REHNBERG K, ROSSI EC: Platelet activation in preeclampsia. Am. J. Obstet. Cynecol (1985) 151(4):494–497.
   PubMed Web of Science ®Google Scholar
• PEKONEN F, RASI V, AMMALA M, VIINIKKA L, YLIKORKALA 0: Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb. Res. (1986) 43(5):553–560.
   PubMed Web of Science ®Google Scholar
• LOUDEN KA, BROUGHTON PF, HEPTINSTALL S, FOX SC, MITCHELL JR, SYMONDS EM: Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br. J. Obstet. Cynaecol (1991) 98(12):1239–1244.
   PubMedGoogle Scholar
• BIELECKI M, ZDRODOWSKA J, BODZENTA-LUKASZYK A, TOMASIAK M, JAROCKI S, BIELECKI DA: [The role of nitric oxide and blood platelets in pathogenesis of preeclampsia]. Cinekol Pol. (1999) 70(3):120–125.
   PubMedGoogle Scholar
• RINK TJ, HALLAM TJ: What turns platelets on. Trends Biochem. Sci. (1984) 9:215–219.
   Web of Science ®Google Scholar
• ••Very good review on basic plateletphysiology.
   Google Scholar
• KILBY MD, PIPKIN FB, COCKBILL S, HEPTINSTALL S, SYMONDS EM: A cross-sectional study of basal platelet intracellular free calcium concentration in normotensive and hypertensive primigravid pregnancies. Clin. Sci. (1990) 78(1):75–80.
   PubMed Web of Science ®Google Scholar
• KILBY MD, PIPKIN FB, SYMONDS EM: Platelet cytosolic calcium in human pregnancy complicated by essential hypertension. Am. Obstet. Cynecol(1993) 169(1):141–143.
   PubMed Web of Science ®Google Scholar
• HAYASHI M, KIUMI F, MITSUYA K: Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia. Am. I Med. ScL (1999) 318(2):115–121.
   PubMed Web of Science ®Google Scholar
• MORRISON R, CRAWFORD J, MACPHERSON M, HEPTINSTALL S: Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb. Haemost. (1985) 54(3):607–611.
   PubMed Web of Science ®Google Scholar
• ROBERTS JM: Endothelial dysfunction in preeclampsia. Semin. Reprod. Endocrinol. (1998) 16:5–15.
   PubMedGoogle Scholar
• LYALL F, GREER IA: Vascular endothelium in normal pregnancy and preeclampsia. Rev Reprod. (1996) 1:107–116.
   PubMedGoogle Scholar
• TAYLOR RN, DE GROOT CJ, CHO YK, LIM KH: Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin. Reprod. Endocrinol (1998) 16:17–31.
   PubMedGoogle Scholar
• GRANGER JP, ALEXANDER BT, BENNETT WA, KHALIL RA: Pathophysiology of pregnancy induced hypertension. Am. Hypertens. (2001) 14:178S–185S.
   Google Scholar
• ••Recent update on the pathophysiology ofpre-eclampsia and PIH.
   Google Scholar
• GRANGER JP, ALEXANDER BT: Abnormal pressure natriuresis in hypertension:role of nitric oxide. Acta Physiol Scand. (2000) 168:161–168.
   PubMedGoogle Scholar
• SELIGMAN SP, BUYON JP, CLANCY RM, YOUNG BK, ABRAMSON SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Cynecol (1994) 171:944–948.
   PubMed Web of Science ®Google Scholar
• CONRAD KP, DUNN MJ: Renal synthesis and urinary excretion of eicosanoids during pregnancy in rats. Am. Physiol (1987) 253:F1197.
   PubMed Web of Science ®Google Scholar
• FRIEDMAN SA: Preeclampsia: a review of the role of prostaglandins. Obstet. Cyriecol (1988) 71:122–137.
   Web of Science ®Google Scholar
• •Good review on a limited topic.
   Google Scholar
• WANG Y, WALSH S, KAY H: Placenta lipid peroxides and thromboxane are increased and prostacyclin is decreased in women iwth preeclampsia. Ain. j Obstet. Cynaecol (1992) 167:946–949.
   PubMed Web of Science ®Google Scholar
• AUGUST P, LINDHEIMER MD: Pathophysiology of preeclampsia. Hypertension (1995) 142:2407–2426.
   Google Scholar
• •Good review but not very up to date.
   Google Scholar
• CONRAD KP, BENYO DF: Placental cytokines and the pathogenesis of preeclampsia. Am. Reprod. Immunol (1997) 37:240–249.
   PubMed Web of Science ®Google Scholar
• KUPFERMINE MJ, PEACEMAN AM, WIGTON TR, REHNBERG KA, SOCOL ML: Tumor necrosis factor-a is elevated in plasma and amniotic fluid of platietns with severe preeclampsia. Am. Obstet. Cynaecol (1994) 170:1752–1759.
   PubMed Web of Science ®Google Scholar
• PIGUET PF, VESIN C, DA KAN C: Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine (2002) 18(4):222–230.
   PubMed Web of Science ®Google Scholar
• LOU J, DONATI YR, JUILLARD P et al.:Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am. J. Pathol (1997) 151(5):1397–1405.
   PubMed Web of Science ®Google Scholar
• RENARD N, NOOIJEN PT, SCHALKWIJK L et al.: VWF release and platelet aggregation in human melanoma after perfusion with TN- a. I Pathol (1995) 176(3):279–287.
   Web of Science ®Google Scholar
• RENESTO P, CHIGNARD M: Tumor necrosis factor-a enhances platelet activation via cathepsin G released from neutrophils. I Immunol (1991) 146(7):2305–2309.
   PubMed Web of Science ®Google Scholar
• MONCADA S, GRYGLEWSKI R, BUNTING S: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 263:663–665.
   PubMed Web of Science ®Google Scholar
• REMUZZI G, MARCHESI D, ZOJA C: Reduced umbilical and placental vascular prostacyclin in severe preeclampsia. Prostaglandins (1980) 20:105–110.
   PubMed Web of Science ®Google Scholar
• KLOCKENBUSCH W, GOECKE TW, KRUSSEL JS, TUTSCHEK BA, CROMBACH G, SCHROR K: Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia. Cynecol Obstet. Invest. (2000) 50(2):103–107.
   PubMed Web of Science ®Google Scholar
• FITZGERALD DJ, ROCKIW, MURRAY R, MAYO G, FITZGERALD GA: Thromboxane A2 synthesis in pregnancy induced hypertension. Lancet (1990) 335:751–754.
   PubMed Web of Science ®Google Scholar
• ISLIM IF, BAREFORD D, EBANKS M, BEEVERS DG: The role of platelets in essential hypertension. Blood Press (1995) 4(4):199–214.
   PubMedGoogle Scholar
• NADAR S, LIP GY: The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curi: Pharm. Des. (2003) 9(21):1715–1732.
   PubMed Web of Science ®Google Scholar
• •Detailed review on the prothrombotic state in hypertension and the influence of drug therapy.
   Google Scholar
• ROY UK, PAN S: A study of use of low dose aspirin in prevention of pregnancy induced hypertension.j Indian. Med. Assoc. (1994) 92(6):188–191.
   Google Scholar
• CASPI E, RAZIEL A, SHERMAN D, ARIELI S, BUKOVSKI I, VVEINRAUB Z: Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. Am. .1. Reprod. Immunol (1994) 31(1):19–24.
   Google Scholar
• Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. italian study of aspirin in pregnancy. Lancet (1993) 341(8842):396–400.
   PubMedGoogle Scholar
• ••One of the major studies involving aspirinin PIH.
   Google Scholar
• VALCAMONICO A, FOSCHINI M, SORE GAROLI M, TARANTINI M, FRUSCA T: Low dose aspirin in pregnancy: a clinical and biochemical study of effects on the newborn. Perham. Med. (1993) 21(3):235–240.
   Web of Science ®Google Scholar
• SCHIFF E, MASHIACH S: The use of lowdose aspirin in pregnancy. Am. I Reprod. ImmunoL (1992) 28(3-4):153–156.
   PubMed Web of Science ®Google Scholar
• RAMAIYA C, MGAYA HN: Low dose aspirin in prevention of pregnancy-induced hypertension in primigravidae at the Muhimbili Medical Center, Dar es Salaam. East. Afr. Med. J. (1995) 72(11):690–693.
   PubMed Web of Science ®Google Scholar
• HAUTH JC, GOLDENBERG RL, PARKER CJ: Low dose asprin therapy to prevent preeclampisa. Am. J. Obstet. Cynaecol (1993) 168:1083–1091.
   PubMed Web of Science ®Google Scholar
• SIBAI BM, GORDON T, THOM E: Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study. The national Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am. Obstet. Cynaecol (1995) 172:642–648.
   Google Scholar
• CLASP (COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY) COLLABORATIVE GROUP: A randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet (1994) 343:619–629.
   PubMed Web of Science ®Google Scholar
• •Good study on aspirin in PIH/ pre-eclampsia.
   Google Scholar
• KNIGHT M, DULEY L, HENDERSON-SMART DJ, KING JF: Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst. Rev (2000) (2):CD000492.
   Google Scholar
• ••Very good review of all the major studies.
   Google Scholar
• SEKI H, KUROMAKI K, TAKEDA S, KINOSHITA K, SATOH K: Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia. Hypertens. Pregnancy (1999) 18(2):157–164.
   PubMed Web of Science ®Google Scholar
• STEYN DW, ODENDAAL HJ: Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet (1997) 350(9087):1267–1271.
   PubMed Web of Science ®Google Scholar
• DEKKER GA, VAN GEIJN HP: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endohtelial cell dysfunction in preeclampsia; therapeutic perspectives. Perinat. Med. (1996) 24:119–139.
   Google Scholar
• OLSON GL, SAADE GR, BUHIMSCHI I, CHWALISZ K, GARFIELD RE: The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia. Am. J. Obstet. CynecoL (1999) 181(3):638–641.
   PubMed Web of Science ®Google Scholar
• SCHIFFL H: Correlation of blood pressure in end-stage renal disease with platelet cytosolic free-calcium concentration. Klinische Wochenschrift (1990) 68(14):718–722.
   PubMedGoogle Scholar
• BLANN AD, NADAR S, LIP GY: Pharmacological modulation of platelet function in hypertension. Hypertension (2003) 42(1):1–7.
   PubMed Web of Science ®Google Scholar
• •Recent comprehensive overview of the effects of drugs on platelets in relation to hypertension.
   Google Scholar
• MAGEE LA, ORNSTEIN MP, VON DADELSZEN P: Management of hypertension in pregnancy. Br. Med. (1999) 318:1332–1336.
   PubMed Web of Science ®Google Scholar
• BORGHI C, ESPOSTI DD, CASSANI A, IMMORDINO V, BOVICELLI L, AMBROSIONI E: The treatment of hypertension in pregnancy. I Hypertens. (2002) 20\(Suppl. 2):552–556.
   Google Scholar
• PAPATSONIS DN, LOK CA, BOS JM, GEIJN HP, DEKKER GA: Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. Ear: I Obstet. Cynecol Reprod. Biol. (2001) 97(2):122–140.
   PubMed Web of Science ®Google Scholar
• LYDAKIS C, LIP GY, BEEVERS M, BEEVERS DG: Atenolol and fetal growth in pregnancies complicated by hypertension. Am. J. Hypertens. (1999) 12(6):541–547.
   PubMed Web of Science ®Google Scholar
• LIP GY, BEEVERS M, CHURCHILL D, SHAFFER LM, BEEVERS DG: Effect of atenolol on birth weight. Am. J. Cardiol (1997) 79(10):1436–1438.
   PubMed Web of Science ®Google Scholar
• MAGEE LA, ELRAN E, BULL SB, LOGAN A, KOREN G: Risks and benefits of 13-receptor blockers for pregnancy hypertension: overview of the randomized trials. Ear: I Obstet. Cynecol Reprod. Biol. (2000) 88(1):15–26.
   PubMed Web of Science ®Google Scholar
• MAGEE LA, DULEY L: Oral 13-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst. Rev (2003) (3):CD002863.
   Google Scholar
• FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION: Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy-United States, Canada, and Israel, 1987-1995. JAMA (1997) 277(15):1193–1194.
   PubMed Web of Science ®Google Scholar
• MASTROBATTISTA JM: Angiotensin converting enzyme inhibitors in pregnancy. &min. Perinatol (1997) 21(2):124–134.
   PubMed Web of Science ®Google Scholar
• LYDAKIS C, BEEVERS M, BEEVERS DG, LIP GY: The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic. Int. J. Clin. Pract. (2001) 55(6):361–367.
   PubMed Web of Science ®Google Scholar